{
  "trial_id": "NCT03013257",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "A diagnosis of GD based on standard clinical criteria (elevated thyroid hormone levels, suppressed TSH, positive TSHR auto-antibody, diffuse goiter \u00b1 high RAI uptake).",
      "label": "met"
    },
    {
      "criterion": "Aged between 18 and 70 years old at the time of informed consent",
      "label": "met"
    },
    {
      "criterion": "Have had at least one GD relapse. A relapse is defined as recurrent or persistent hyperthyroidism despite completing a continued course of ATDs for 18 months or more.",
      "label": "unknown"
    },
    {
      "criterion": "Indicated for RAI treatment",
      "label": "met"
    },
    {
      "criterion": "Valid consent is obtained",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Prefer or have clear indications for surgery (such as those with large compressive goiter, suspected or documented thyroid malignancy, wishing to become pregnant within 6 months or with moderate to severe GO).",
      "label": "not_met"
    },
    {
      "criterion": "Have pre-existing vocal cord palsy",
      "label": "unknown"
    }
  ],
  "notes": "Patient has metastatic papillary thyroid cancer and is experiencing worsening dysphagia, poor oral intake, weight loss, and lethargy.",
  "_meta": {
    "topic_id": "11",
    "trial_id": "NCT03013257",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}